Recombinant Adenovirus-Mediated HIF-lα Ameliorates Neurological Dysfunction by Improving Energy Metabolism in Ischemic Penumbra After Cerebral Ischemia-Reperfusion in Rats
Wenmei Zhou,Tao Tao,Wenfeng Yu,Wanfu Wu,Zhirong Hui,Hongliang Xu,Yaqi Li,Ying Zhang,Xiaohui Yang
DOI: https://doi.org/10.2147/NDT.S389022
IF: 2.989
2023-04-07
Neuropsychiatric Disease and Treatment
Abstract:Wenmei Zhou, 1 Tao Tao, 1 Wenfeng Yu, 2 Wanfu Wu, 3 Zhirong Hui, 1 Hongliang Xu, 1 Yaqi Li, 4 Ying Zhang, 5 Xiaohui Yang 1, 6 1 Department of Rehabilitation Medicine, Guizhou Provincial People's Hospital, Guiyang, Guizhou, 550002, People's Republic of China; 2 Department of Human Anatomy, Basic Medical College, Guizhou Medical University, Guiyang, Guizhou, 550004, People's Republic of China; 3 Department of Biology and Biochemistry, University of Houston, Houston, TX, 77204, USA; 4 Emergency Department, Guizhou Provincial People's Hospital, Guiyang, Guizhou, 550002, People's Republic of China; 5 Department of Chinese Traditional Medicine, Zunyi Medical and Pharmaceutical College, Zunyi, Guizhou, 563006, People's Republic of China; 6 Department of Rehabilitation Medicine, The Affiliated Hospital Guizhou Medical University, Guiyang, Guizhou, 550001, People's Republic of China Correspondence: Tao Tao, Tel +86 13985162824, Email Background: Hypoxia inducible factor-1α (HIF-1α) regulates glucose metabolism during ischemia. This study investigated the effect of recombinant adenovirus HIF-1ɑ on neurological function and energy metabolism in a rat cerebral ischemia-reperfusion model. Methods: Rats were divided into four groups: sham-operated (Sham) group, cerebral ischemia-reperfusion (CIR) group, recombinant adenovirus empty vector (Ad) group, and recombinant adenovirus-mediated HIF-1α (AdHIF-1α) group. The AdHIF-1α group and the Ad group were injected with AdHIF-1α and Ad in the lateral ventricle. The mNSS was performed at post-ischemia day 0 (P0) and P1, P14 and P28. At P14, the cerebral infarct volume was compared. At P28, HE staining, Nissl stains and TUNEL staining were performed. The expression of HIF-1α, GLUT1 and PFKFB3 were evaluated by Western Blot and immunohistochemistry. High performance liquid chromatography (HPLC) was used to determine the expression of GLUT1 and PFKFB3, and the level of energy metabolites: ATP, ADP and AMP. Results: mNSS scores in the AdHIF-1α group were consistently lower than those in the CIR and Ad groups from P14 (P < 0.05) and Ad groups (P < 0.05). The cerebral infarct volume was reduced in the AdHIF-1α group compared with that in CIR group and Ad group (P < 0.05). At P28, HE showed better pathological changes in AdHIF-1α group. The number of Nissl bodies was increased in the AdHIF-1α group compared with the CIR and Ad groups (P < 0.05). The number of apoptotic cells in the AdHIF-1α group was fewer than that in the CIR and Ad groups (P < 0.05). The expression of HIF-1α, GLUT1 and PFKFB3 was significantly higher in the AdHIF-1α group compared with the CIR and Ad groups (P < 0.05). The ATP, ADP and AMP in the ischemic penumbra were also higher in the AdHIF-1α group (P < 0.05). Conclusion: HIF-lα promoted neurological function recovery and decreased cerebral infarct volume in rats after cerebral ischemia-reperfusion injury by improving energy metabolism. Keywords: cerebral ischemia-reperfusion injury, HIF-lα, energy metabolism, glucose transporter protein-1, GLUT1, 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3, PFKFB3 To restore the cerebral blood supply to the ischemic area in the time window is one of the key treatments for cerebral ischemia. In recent years, the mortality rate of cerebral ischemia has sharply decreased with the popularization of thrombolysis and endovascular techniques. However, reperfusion after ischemia may further aggravate the damage to the ischemic brain tissue and lead to neurological dysfunction due to the sudden increase of oxygen while increasing the blood oxygen supply, which is defined as cerebral ischemia-reperfusion injury (CIRI). 1 CIRI is a pathological phenomenon caused by cerebral ischemic stroke. Hypoxia-inducible factor-1α (HIF-1α) is the initiator that triggers endogenous protection pathways during hypoxia and ischemia by promoting angiogenesis, increasing erythrocytes, promoting cell migration, and inhibiting apoptosis by regulating the expression of its target genes. 2 Our group has successfully constructed recombinant adenovirus-mediated hypoxia inducible factor-1 alpha (AdHIF-1α) and demonstrated that the recombinant adenovirus could be successfully introduced into the lateral ventricle. The treatment of AdHIF-1α in tMCAO rat model showed neuroprotection by decreasing apoptosis of neuronal cells. 3,4 Increasing the expression of endogenous HIF-1α during cerebral ischemia can improve motor and cognitive functions in rats, 5,6 but the cerebral protective mechanisms of HIF-1α need further investigation. Previous studies have sh -Abstract Truncated-
psychiatry,clinical neurology